Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

6.37
0.0000
Volume:- -
Turnover:1.46M
Market Cap:14.25M
PE:-0.66
High:6.37
Open:6.37
Low:6.37
Close:6.37
52wk High:597.60
52wk Low:3.08
Shares:2.24M
Float Shares:966.60K
Volume Ratio:- -
T/O Rate:- -
Dividend:0.00
Dividend Rate:0.02%
EPS(TTM):-9.6620
EPS(LYR):-502.4648
ROE:-276.80%
ROA:-102.83%
PB:3.93
PE(LYR):-0.01

Loading ...

Feb 08, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 08, 2024

Correspondence

Form CORRESP - Correspondence
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 19, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 13, 2024

Major Issues Report

Form 8-K - Current report
Jan 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 26, 2023

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 29, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Nov 29, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Correspondence

Form CORRESP - Correspondence
Sep 08, 2023

Major Issues Report

Form 8-K - Current report